Screening Adults Aged 40-70 Would Find Undiagnosed Type 2 Diabetes Cases Much Earlier
Using a standard diabetes test to screen all adults in U.K. aged 40-70 years would find undiagnosed cases of type 2 diabetes much earlier.
Read MorePosted by Andy Lundin | Nov 24, 2022 | Diabetes & Metabolic Diseases |
Using a standard diabetes test to screen all adults in U.K. aged 40-70 years would find undiagnosed cases of type 2 diabetes much earlier.
Read MorePosted by Chris Wolski | Nov 22, 2022 | Covid 19 |
The U.S. Food. and Drug Administration (FDA) issued emergency use authorizations for two COVID-19 Antigen Home Tests.
Read MorePosted by Chris Wolski | Nov 21, 2022 | Controls, Molecular Diagnostics |
ZeptoMetrix, an Antylia Scientific company, launches the NATtrol Bacteriophage MS2 quantitative stock: NATMS2-STQ.
Read MorePosted by Chris Wolski | Nov 21, 2022 | Covid 19 |
Researchers have shown that patients with acute COVID-19 infection have increased levels of the cytokine IL-26 in their blood.
Read MorePosted by Andy Lundin | Nov 17, 2022 | Molecular Diagnostics |
DiaSorin received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Simplexa Congenital CMV Direct kit.
Read More